The effect of hydroxy safflower yellow A on coronary heart disease through Bcl‑2/Bax and PPAR‑γ

Dayan Zhou(First People's Hospital of Chongqing), Qiang Xu(Wannan Medical College)
Experimental and Therapeutic Medicine
November 1, 2017
10.3892/etm.2017.5414
Cited by 28

Related Papers

Enasidenib in mutant IDH2 relapsed or refractory acute myeloid leukemia
|Blood|2017|1.5k
CUG-binding protein 1 regulates HSC activation and liver fibrogenesis
|Nature Communications|2016|86
Deciphering the pathogenic role of a variant with uncertain significance for short QT and Brugada syndromes using gene‐edited human‐induced pluripotent stem cell‐derived cardiomyocytes and preclinical drug screening
|Clinical and Translational Medicine|2021|22